Net Assets for Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported net assets is $31.26B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$31.26B
YoY change
+6.5%
5Y CAGR
+23.2%
Peak year (2025)
$31.26B
Latest annual
$31.26B
Net Assets history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
Net Assets history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $31.26B | +6.5% | ||
| 2024 | $29.35B | +13.0% | ||
| 2023 | $25.97B | +14.6% | ||
| 2022 | $22.66B | +20.8% | ||
| 2021 | $18.77B | +70.2% | ||
| 2020 | $11.03B | -0.6% | ||
| 2019 | $11.09B | +26.6% | ||
| 2018 | $8.76B | +42.5% | ||
| 2017 | $6.14B | +38.1% | ||
| 2016 | $4.45B | +21.7% | ||
| 2015 | $3.65B | +43.8% | ||
| 2014 | $2.54B | +30.2% | ||
| 2013 | $1.95B | +56.7% | ||
| 2012 | $1.25B | +156.4% | ||
| 2011 | $485.73M | -8.0% | ||
| 2010 | $527.82M | +33.0% | ||
| 2009 | $396.76M | -5.3% | ||
| 2008 | $418.85M | -9.0% | ||
| 2007 | $460.27M | +112.5% | ||
| 2006 | $216.62M | +90.0% | ||
| 2005 | $114.00M | -37.5% | ||
| 2004 | $182.54M | +32.6% | ||
| 2003 | $137.64M | -5.7% | ||
| 2002 | $145.98M | -45.2% | ||
| 2001 | $266.36M | +46.2% | ||
| 2000 | $182.13M | +66.3% | ||
| 1999 | $109.50M | -16.5% | ||
| 1998 | $131.20M | -5.5% | ||
| 1997 | $138.90M | +29.9% | ||
| 1996 | $106.90M | +57.4% | ||
| 1995 | $67.90M | +1.2% | ||
| 1994 | $67.10M | -31.8% | ||
| 1993 | $98.40M | +12.8% | ||
| 1992 | $87.20M | -17.9% | ||
| 1991 | $106.20M | +770.5% | ||
| 1990 | $12.20M | — |
Net Assets values are taken from Regeneron Pharmaceuticals's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Regeneron Pharmaceuticals (REGN) net assets is $31.26B – grew 6.5% year-over-year.
Regeneron Pharmaceuticals net assets compound annual growth for the 2020–2025 (5 years) window is +23.2%, sustaining 5 straight years of year-over-year growth.
Across the available history, net assets reached its high of $31.26B in 2025 and its low of $12.20M in 1990.
Among 8 Healthcare peers, Regeneron Pharmaceuticals (REGN) ranks 6th; the peer median for net assets is $50.64B.
Regeneron Pharmaceuticals Net Assets by Year
Regeneron Pharmaceuticals Net Assets 2025: $31.26B
Regeneron Pharmaceuticals net assets in 2025 was $31.26B, grew 6.5% from 2024. This figure represents the highest annual value in the available history.
Regeneron Pharmaceuticals Net Assets 2024: $29.35B
Regeneron Pharmaceuticals net assets in 2024 was $29.35B, grew 13.0% from 2023.
Regeneron Pharmaceuticals Net Assets 2023: $25.97B
Regeneron Pharmaceuticals net assets in 2023 was $25.97B, grew 14.6% from 2022.
Regeneron Pharmaceuticals Net Assets 2022: $22.66B
Regeneron Pharmaceuticals net assets in 2022 was $22.66B, grew 20.8% from 2021.
Regeneron Pharmaceuticals Net Assets 2021: $18.77B
Regeneron Pharmaceuticals net assets in 2021 was $18.77B.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers — Net Assets
Companies in the same sector as Regeneron Pharmaceuticals, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Regeneron Pharmaceuticals's net assets?
- Latest reported net assets for Regeneron Pharmaceuticals (REGN) is $31.26B (period ending December 31, 2025).
How has Regeneron Pharmaceuticals net assets changed year-over-year?
- Regeneron Pharmaceuticals (REGN) net assets changed +6.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Regeneron Pharmaceuticals net assets?
- Regeneron Pharmaceuticals (REGN) net assets compound annual growth rate is +23.2% over the most recent 5 years available.
When did Regeneron Pharmaceuticals net assets hit its highest annual value?
- Regeneron Pharmaceuticals net assets reached its highest annual value of $31.26B in 2025.
What was Regeneron Pharmaceuticals net assets in 2024?
- Regeneron Pharmaceuticals (REGN) net assets in 2024 was $29.35B.
What was Regeneron Pharmaceuticals net assets in 2025?
- Regeneron Pharmaceuticals (REGN) net assets in 2025 was $31.26B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
REGN Overview
Company profile, financial tools, and key metrics
REGN Revenue Counter
Earns $454.81 every second. See per minute, hour, and day.
REGN Earnings Counter
Earns $142.85 per second net profit. See per minute, hour, and day.
REGN Economic Scale
Exceeds Rwanda's GDP. Compare with world economies.
REGN What If Invested
What if you had invested $1,000? See historical returns from any date.
REGN How It Makes Money
Discover visual breakdown of $14.34B in revenue — where it comes from and where it goes.
REGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
REGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
REGN Daily Price Character
Explosive · 47.1% historical win rate (green days). Streaks & record days.
REGN Buybacks
4.33% TTM buyback yield. Shareholder yield & SBC comparison.
REGN Dividend Profile
Yield: 0.52%. See full history.
REGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
REGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.